Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.70)
# 767
Out of 5,012 analysts
457
Total ratings
46.2%
Success rate
8.77%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVAX Evaxion | Maintains: Buy | $14 → $16 | $6.25 | +156.00% | 13 | Sep 25, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $7.14 | +180.11% | 3 | Sep 23, 2025 | |
| IPHA Innate Pharma | Downgrades: Neutral | n/a | $2.01 | - | 17 | Sep 18, 2025 | |
| DNTH Dianthus Therapeutics | Reiterates: Buy | $40 | $35.03 | +14.19% | 7 | Sep 8, 2025 | |
| PSNL Personalis | Reiterates: Buy | $8.5 | $8.30 | +2.41% | 17 | Sep 8, 2025 | |
| CLGN CollPlant Biotechnologies | Reiterates: Buy | $11 | $2.34 | +370.09% | 12 | Aug 21, 2025 | |
| PGEN Precigen | Reiterates: Buy | $8.5 | $3.35 | +154.11% | 13 | Aug 19, 2025 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $5 | $2.86 | +74.83% | 10 | Aug 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $50 → $66 | $48.93 | +34.89% | 9 | Aug 18, 2025 | |
| AEMD Aethlon Medical | Reiterates: Neutral | $1.5 | $0.76 | +97.78% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $33.56 | +78.78% | 14 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3.5 | $3.42 | +2.34% | 17 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.70 | +76.99% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $80 | $73.78 | +8.43% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $31 | $11.07 | +180.04% | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $130 | $84.84 | +53.23% | 4 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.84 | +280.43% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $21.17 | +65.33% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $90 | $4.78 | +1,782.85% | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $17.55 | +76.64% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.77 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.22 | +146.91% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.05 | -2.44% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $89.75 | +61.56% | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $60 | $5.31 | +1,029.94% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $2.51 | +39.44% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.16 | +779.63% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.72 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.24 | +65.09% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.40 | +7,400.00% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.10 | +390.27% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.82 | +1,479.78% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $23.98 | +191.91% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $34.27 | +75.08% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $8.32 | +296.63% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.28 | +1,696.62% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.80 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.13 | +54.28% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.23 | +519.20% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $6.39 | +40.85% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.50 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.64 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.56 | +476.92% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $2.15 | +1,062.79% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.95 | +156.41% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $4.96 | +2,319.35% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.97 | +509.20% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.83 | +2,301.25% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $19.94 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $6.91 | -13.17% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $2.04 | +635.29% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $9.16 | +260.26% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $13.68 | -30.56% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.83 | +764,927.32% | 1 | Mar 5, 2020 |
Evaxion
Sep 25, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $6.25
Upside: +156.00%
Actuate Therapeutics
Sep 23, 2025
Reiterates: Buy
Price Target: $20
Current: $7.14
Upside: +180.11%
Innate Pharma
Sep 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.01
Upside: -
Dianthus Therapeutics
Sep 8, 2025
Reiterates: Buy
Price Target: $40
Current: $35.03
Upside: +14.19%
Personalis
Sep 8, 2025
Reiterates: Buy
Price Target: $8.5
Current: $8.30
Upside: +2.41%
CollPlant Biotechnologies
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $2.34
Upside: +370.09%
Precigen
Aug 19, 2025
Reiterates: Buy
Price Target: $8.5
Current: $3.35
Upside: +154.11%
Pyxis Oncology
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $2.86
Upside: +74.83%
Celcuity
Aug 18, 2025
Maintains: Buy
Price Target: $50 → $66
Current: $48.93
Upside: +34.89%
Aethlon Medical
Aug 14, 2025
Reiterates: Neutral
Price Target: $1.5
Current: $0.76
Upside: +97.78%
Aug 14, 2025
Reiterates: Buy
Price Target: $60
Current: $33.56
Upside: +78.78%
Aug 13, 2025
Maintains: Buy
Price Target: $7 → $3.5
Current: $3.42
Upside: +2.34%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.70
Upside: +76.99%
Aug 7, 2025
Maintains: Buy
Price Target: $73 → $80
Current: $73.78
Upside: +8.43%
Aug 7, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $11.07
Upside: +180.04%
Jun 24, 2025
Maintains: Buy
Price Target: $110 → $130
Current: $84.84
Upside: +53.23%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.84
Upside: +280.43%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $21.17
Upside: +65.33%
May 27, 2025
Assumes: Buy
Price Target: $90
Current: $4.78
Upside: +1,782.85%
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $17.55
Upside: +76.64%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.77
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.22
Upside: +146.91%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.05
Upside: -2.44%
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $89.75
Upside: +61.56%
May 6, 2025
Maintains: Buy
Price Target: $135 → $60
Current: $5.31
Upside: +1,029.94%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $2.51
Upside: +39.44%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.16
Upside: +779.63%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.72
Upside: -
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $4.24
Upside: +65.09%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.40
Upside: +7,400.00%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $5.10
Upside: +390.27%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $0.82
Upside: +1,479.78%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $23.98
Upside: +191.91%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $34.27
Upside: +75.08%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $8.32
Upside: +296.63%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.28
Upside: +1,696.62%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $14.80
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.13
Upside: +54.28%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $3.23
Upside: +519.20%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $6.39
Upside: +40.85%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.50
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.64
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.56
Upside: +476.92%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $2.15
Upside: +1,062.79%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.95
Upside: +156.41%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $4.96
Upside: +2,319.35%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.97
Upside: +509.20%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.83
Upside: +2,301.25%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $19.94
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $6.91
Upside: -13.17%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $2.04
Upside: +635.29%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $9.16
Upside: +260.26%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $13.68
Upside: -30.56%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.83
Upside: +764,927.32%